S. Hwang

发表

Acquired lipodystrophy associated with immune checkpoint inhibitors.

Subashini Gnanendran, James Miller, C. Archer, 2020, Melanoma research.

PD‐1 inhibitor‐associated lichenoid inflammation with incidental suprabasilar acantholysis or vesiculation—Report of 4 cases

P. Fernández-Peñas, S. Hwang, C. Zhao, 2017, Journal of cutaneous pathology.

Histologic Assessment of Lichenoid Dermatitis Observed in Patients With Advanced Malignancies on Antiprogramed Cell Death–1 (anti–PD-1) Therapy With or Without Ipilimumab

P. Fernández-Peñas, S. Hwang, S. Chou, 2017, The American Journal of dermatopathology.

Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.

K. Byth, R. Kefford, M. Carlino, 2016, Journal of the American Academy of Dermatology.

Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies.

M. Carlino, P. Fernández-Peñas, S. Hwang, 2016, Melanoma research.

Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature

P. Fernández-Peñas, S. Hwang, C. Zhao, 2018, Melanoma research.

Volunteering at an adventure camp for epidermolysis bullosa

D. Murrell, S. Hwang, Min-hee Kim, 2012, The Medical journal of Australia.

Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab).

P. Fernández-Peñas, S. Hwang, 2018, Current problems in dermatology.

Ipilimumab-induced acute generalized exanthematous pustulosis in a patient with metastatic melanoma.

Raghwa N. Sharma, P. Fernández-Peñas, S. Hwang, 2016, Melanoma research.

Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma

M. Carlino, P. Fernández-Peñas, S. Hwang, 2018, Journal of immunotherapy.

Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors

Subashini Gnanendran, James Miller, S. Hwang, 2020, Current Treatment Options in Oncology.

Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study

P. Fernández-Peñas, S. Hwang, C. Zhao, 2017, The Australasian journal of dermatology.

PD-1 inhibitors induced bullous lichen planus-like reactions: a rare presentation and report of three cases.

R. Hui, P. Fernández-Peñas, S. Hwang, 2016, Melanoma research.

Dermatology and Immunology

S. Doggett, P. Fernández-Peñas, S. Hwang, 2018 .

Time-Dependent Measurement of Adverse Events.

K. Byth, P. Fernández-Peñas, S. Hwang, 2015, JAMA dermatology.

Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand☆☆☆★

D. Murrell, J. Walton, S. Hwang, 2015, International journal of women's dermatology.

Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand☆☆☆

D. Murrell, J. Walton, S. Hwang, 2015, International journal of women's dermatology.

Prevalence of anemia in patients with epidermolysis bullosa registered in Australia

D. Murrell, S. Hwang, B. Daniel, 2015, International journal of women's dermatology.

Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management.

S. Hwang, P. Fernández-Peñas, S. Hwang, 2017, Actas dermo-sifiliograficas.

The older patient presenting with itch and a recent medication change.

G. Bennett, S. Hwang, L. Turner, 2020, Australian journal of general practice.

Acute Truncal Lymphedema Secondary to Axillary Metastatic Melanoma Presenting Like Cellulitis

M. Carlino, B. Kong, P. Fernández-Peñas, 2017, Case reports in medicine.

Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management.

P. Fernández-Peñas, S. Hwang, Giuliana Carlos, 2017, Actas dermo-sifiliograficas.